The TRANSVAC call for free services in (pre-)clinical vaccine development is going into its 5th round
Date: 21/12/2011
The TRANSVAC consortium aims to accelerate the development of promising vaccine candidates by bridging the gap between bench research and clinical trials through the provision of expertise on e.g. antigen discovery, formulation, in vivo models and antigen production. The project aims to be a European driving force for vaccine development by establishing an efficient sustainable collaborative infrastructure based on a shared visions and goal. In order to support and accelerate vaccine development in Europe, the TRANSVAC project is providing a vaccine development platform that may be accessed for free by innovative European groups.
Eleven projects have been funded so far. Please visit the selected project website. There are free service slots remaining in 1) Animal models 2) Adjuvants formulation of your Antigen 3) Reagent supply and development by NIBSC, and finally, 4) global analyses platform (microarrays/deep sequencing) for e.g. biomarker research.
We are calling upon receiving more innovative and excellent proposals to use the remaining services. I am inviting you to pass this message on including the enclosed PDF with further information on the call to your colleagues and/or network of scientists working in vaccine development. It would be much appreciated if you could include it into any relevant newsletters or website news posts. All information is available at http://www.transvac.org/open-call
The next cut-off date is 31 January 2012.
Finally, the consortium wants to draw your attention to the fact that the consortium is opening up for new partners through a call for new partners.
Please visit our website for more information: http://www.transvac.org/call-new-partners
< back to the list